BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.

Other languages Biohaven Pharmaceutical Holding Company Ltd.

Equities

BHVN

VGG111961055

Market Closed - Nyse Other stock markets 04:00:02 2024-05-16 pm EDT			5-day change	1st Jan Change
38.46 ^USD	+3.72%		-7.01%	-74.66%

May. 15	Biohaven Insider Bought Shares Worth $512,877, According to a Recent SEC Filing	MT
May. 14	Biohaven Insider Bought Shares Worth $1,002,470, According to a Recent SEC Filing	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biohaven Insider Bought Shares Worth $512,877, According to a Recent SEC Filing	May. 15
Biohaven Insider Bought Shares Worth $1,002,470, According to a Recent SEC Filing	May. 14
Biohaven Shares Fall as Q1 Loss Widens, Misses Estimates	May. 10
Biohaven Insider Bought Shares Worth $999,169, According to a Recent SEC Filing	Apr. 25
Biohaven Shares Rise After Closing of Public Offering, Disclosure of Stock Purchase by CEO	Apr. 23
Biohaven Insider Bought Shares Worth $7,999,961, According to a Recent SEC Filing	Apr. 23
Biohaven Insider Bought Shares Worth $4,999,991, According to a Recent SEC Filing	Apr. 23
Biohaven Prices $230 Million Public Share Offering	Apr. 18
Biohaven Q4 Non-GAAP Net Loss Widens, Shares Fall After-Hours	Feb. 29
Biohaven Insider Sold Shares Worth $459,663, According to a Recent SEC Filing	Jan. 02
Biohaven Pharmaceutical Q3 Net Loss Narrows	Nov. 14
Biohaven Pharmaceutical Says Obesity Treatment Candidate Reduces Fat, Improves Lean Mass	23-10-16
Biohaven Insider Bought Shares Worth $9,999,990, According to a Recent SEC Filing	23-10-11
Biohaven Insider Bought Shares Worth $9,999,990, According to a Recent SEC Filing	23-10-10
Biohaven Insider Bought Shares Worth $499,994, According to a Recent SEC Filing	23-10-06
Biohaven Insider Bought Shares Worth $402,094, According to a Recent SEC Filing	23-10-06
Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday	23-10-03
Biohaven Prices Common Stock Offering at $22 per Share	23-10-03
Biohaven Launches $200 Million Share Sale in Public Offering	23-10-02
Biohaven Director Buys 50,000 Shares for $922,180	23-08-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biohaven Pharmaceutical Holding Company Ltd.

Equities

BHVN

VGG111961055

Other languages

Filters